Capital Public Radio: 80% of Hepatitis B Infected Asians Will Develop Liver Cancer; polyDNA Recommends Gene-Eden-VIR and Novirin against the Latent HBV

“About ten percent of Asians have the virus (hepatitis B) and 80-percent of them will get liver cancer,” according to a news report published on April 25, 2014 on Capradio.org (1). polyDNA recommends that infected individuals ask their doctors about Gene-Eden-VIR and Novirin, which were proven to reduce viral symptoms in a post-marketing clinical study that followed FDA guidelines.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
We recommend that Asian Americans ask their doctors about Gene-Eden-VIR and Novirin. The formula of these natural antivirals was designed to help the immune system target latent viruses. – Mike Evans, polyDNA

Rochester, NY (PRWEB) May 04, 2014

Asians infected with hepatitis B have a high risk of developing liver cancer (1). Dr. Moon Chen said that hepatitis B is a principal risk factor for liver cancer. The virus is typically transmitted from mother to child. However, development of symptoms may take 20-30 years. This gives responsible individuals time to medically respond to the infection. polyDNA recommends responding to a hepatitis B infection by talking to the doctor about Gene-Eden-VIR and Novirin. The formula of these natural products was clinically proven to reduce symptoms of HBV infection in a study that followed FDA guidelines.

Asian Americans are more likely to acquire a Hepatitis B infection and suffer from long-term, chronic HBV disease. In fact, “Asian Americans are 5.5 times more likely to develop chronic Hepatitis B, as compared to Whites.” (See The Office of Minority Health, from August 9, 2013) (2). Moreover, “Asian American women are 1.5 times more likely to die from viral hepatitis, as compared to Non-Hispanic Whites (2).”

The latest CDC statistics show that Asian American Hepatitis B cases made up almost 25% of all reported Hepatitis B infections in 2010 (See the CDC, from August 20, 2012) (3). In these patients, “The natural course of chronic HBV infection … (among those)… who acquired the disease at an early age, including those infected perinatally (time immediately before and after birth), can be classified into four distinct phases: immune tolerance, immune clearance, inactive carrier (low or non-replication), and reactivation.” (See the journal of Digestive Diseases and Sciences, published in February 12, 2014) (4). In the study, authors wrote that “our findings suggested some patients that were previously thought to have inactive disease phases … may actually be in active HBV disease phases (4).”

In other words, even though doctors thought the virus was inactive, and doing nothing, it was actually damaging the patient. Therefore, polyDNA urges people not to be complacent.

“Hepatitis B is caused by infection with the Hepatitis B virus (HBV). The incubation period from the time of exposure to onset of symptoms is 6 weeks to 6 months. HBV is found in highest concentrations in blood and in lower concentrations in other body fluids (e.g., semen, vaginal secretions, and wound exudates).” (See the CDC, from May 16, 2012) (5).

“We recommend that Asian Americans ask their doctors about Gene-Eden-VIR and Novirin. The formula of these natural antivirals was designed to help the immune system target latent viruses.” – Mike Evans, polyDNA

As far as we know, the only two products currently available that target latent viruses are Gene-Eden-VIR, and Novirin.

Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (6).

Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

Up to 70% of those studied reported a decrease in symptoms associated with CMV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (6).

Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.

A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (3).
To learn more about Novirin, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) UC Davis Medical Encourages Asians To Get Hep B Test. Published on April 25, 2014.
http://www.capradio.org/articles/2014/04/25/uc-davis-medical-encourages-asians-to-get-hep-b-test/

(2) U.S. Department of Health and Human Services, Office of Minority Health - Hepatitis and Asian Americans. Last reviewed on August 9, 2013.
http://minorityhealth.hhs.gov/templates/content.aspx?lvl=3&lvlid=541&ID=6495

(3) CDC - Viral Hepatitis Surveillance – United States, 2010. From August 20, 2012.
http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/index.htm

(4) Clinical Presentation and Disease Phases of Chronic Hepatitis B Using Conventional Versus Modified ALT Criteria in Asian Americans. Published on February 12, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/24519522

(5) CDC - Hepatitis B Information for Health Professionals. Last updated on May 16, 2012.
http://www.cdc.gov/hepatitis/hbv/

(6) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(7) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.